Science
What becomes possible when antibodies do more.

Extending the reach of antibodies to new diseases.
95% of today's therapeutic antibodies work by blocking biology, leaving an enormous opportunity for biologics that can do more. By expanding the mechanisms antibodies can use, Metaphore broadens the scope of diseases antibody medicines can treat.
Many diseases require pathways to be activated. Others require signals to be tuned, multiple targets to be engaged, or several functions to work together in one simple medicine. These are therapeutic challenges that blocking alone cannot solve.
Metaphore's platform makes these antibody actions designable. This unlocks a wider therapeutic landscape, enabling new mechanisms, new targets, and new treatment possibilities for millions of patients.
What this enables.
To treat many diseases, you need medicines that do more than block biology.
Expanding what antibodies can do.
Many diseases rely more than blocking. Metaphore is designing antibodies with new therapeutic actions to address more complex biology.
Our Platform
Where living biology directs antibody design.
Metaphore’s platform combines high throughput live-cell experimentation with machine learning to design antibodies that go beyond blocking.
Biology is constantly in motion. Proteins interact, change shape, and send complex signals that determine how cells behave. Yet traditional antibody discovery often begins with static structures or binding outside a protein’s natural environment—revealing where an antibody binds, but not always what it will do in a living system.
Instead of relying on static protein structures, Metaphore starts with functional data from living systems. Functional data describe what a molecule does beyond binding, including receptor activation, downstream signaling, and gene transcription. We measure biological activity in living cells to understand what drives pathway activation, signaling bias, selectivity, multi-target engagement, and other complex therapeutic actions.
These data are interpreted by our AI/ML models that identify the features responsible for specific functional outcomes. Those insights become the foundation for designing antibody medicines with new capabilities.
With each design cycle, our platform learns from new functional data, improving its ability to design antibodies for specific therapeutic actions. This approach enables Metaphore to design molecules with precise therapeutic actions in weeks instead of years bringing our medicines to patients, faster.

Learn
Measure functional activity in living cells at scale to understand how proteins behave.
Design
Use functional data and machine learning to identify features that drive desired biological actions and design antibody candidates.
Build
Create antibody candidates designed for the intended therapeutic action.
Test
Refine and optimize properties through machine learning to test candidates in living systems and use the results to refine their function and medicine-like properties.
Applications
Patient impact
New antibody actions. New possibilities for patients.
Metaphore is building this platform to create antibody medicines for diseases where blocking alone is not enough. By making new therapeutic actions designable, we aim to extend the reach of antibody medicine and create new treatment possibilities for patients.
